Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

MARKSANS PHARMA. vs JUBILANT PHARMOVA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    MARKSANS PHARMA. JUBILANT PHARMOVA MARKSANS PHARMA./
JUBILANT PHARMOVA
 
P/E (TTM) x 40.3 31.2 128.9% View Chart
P/BV x 6.8 3.3 205.3% View Chart
Dividend Yield % 0.2 0.4 43.6%  

Financials

 MARKSANS PHARMA.   JUBILANT PHARMOVA
EQUITY SHARE DATA
    MARKSANS PHARMA.
Mar-24
JUBILANT PHARMOVA
Mar-24
MARKSANS PHARMA./
JUBILANT PHARMOVA
5-Yr Chart
Click to enlarge
High Rs179627 28.6%   
Low Rs70279 24.9%   
Sales per share (Unadj.) Rs48.0420.8 11.4%  
Earnings per share (Unadj.) Rs6.94.6 152.2%  
Cash flow per share (Unadj.) Rs8.628.5 30.1%  
Dividends per share (Unadj.) Rs0.605.00 12.0%  
Avg Dividend yield %0.51.1 43.7%  
Book value per share (Unadj.) Rs45.6340.2 13.4%  
Shares outstanding (eoy) m453.16159.28 284.5%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.61.1 240.3%   
Avg P/E ratio x17.999.3 18.0%  
P/CF ratio (eoy) x14.515.9 91.2%  
Price / Book Value ratio x2.71.3 204.9%  
Dividend payout %8.6109.5 7.9%   
Avg Mkt Cap Rs m56,33372,158 78.1%   
No. of employees `000NANA-   
Total wages/salary Rs m2,93622,160 13.3%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m21,77467,029 32.5%  
Other income Rs m504687 73.4%   
Total revenues Rs m22,27867,716 32.9%   
Gross profit Rs m4,5867,560 60.7%  
Depreciation Rs m7433,819 19.4%   
Interest Rs m1122,723 4.1%   
Profit before tax Rs m4,2351,705 248.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,086978 111.1%   
Profit after tax Rs m3,149727 433.1%  
Gross profit margin %21.111.3 186.7%  
Effective tax rate %25.657.4 44.7%   
Net profit margin %14.51.1 1,333.4%  
BALANCE SHEET DATA
Current assets Rs m18,62536,322 51.3%   
Current liabilities Rs m3,89818,890 20.6%   
Net working cap to sales %67.626.0 260.1%  
Current ratio x4.81.9 248.5%  
Inventory Days Days1013 75.4%  
Debtors Days Days7650 152.3%  
Net fixed assets Rs m8,18574,397 11.0%   
Share capital Rs m453158 286.8%   
"Free" reserves Rs m20,19754,036 37.4%   
Net worth Rs m20,65154,194 38.1%   
Long term debt Rs m031,671 0.0%   
Total assets Rs m26,810113,158 23.7%  
Interest coverage x38.81.6 2,386.3%   
Debt to equity ratio x00.6 0.0%  
Sales to assets ratio x0.80.6 137.1%   
Return on assets %12.23.0 399.0%  
Return on equity %15.21.3 1,136.7%  
Return on capital %21.15.2 408.2%  
Exports to sales %00-   
Imports to sales %6.93.2 219.1%   
Exports (fob) Rs mNANA-   
Imports (cif) Rs m1,5112,124 71.2%   
Fx inflow Rs m8,4667,307 115.9%   
Fx outflow Rs m1,5112,124 71.2%   
Net fx Rs m6,9545,183 134.2%   
CASH FLOW
From Operations Rs m2,3049,713 23.7%  
From Investments Rs m-1,408-6,079 23.2%  
From Financial Activity Rs m-687-4,325 15.9%  
Net Cashflow Rs m208-575 -36.2%  

Share Holding

Indian Promoters % 43.9 47.4 92.6%  
Foreign collaborators % 0.0 3.3 -  
Indian inst/Mut Fund % 25.4 23.6 107.7%  
FIIs % 21.3 17.9 118.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 56.1 49.3 113.8%  
Shareholders   248,845 89,456 278.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare MARKSANS PHARMA. With:   DIVIS LABORATORIES    SUN PHARMA    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on MARKSANS PHARMA. vs Jubilant Pharmova

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

MARKSANS PHARMA. vs Jubilant Pharmova Share Price Performance

Period MARKSANS PHARMA. Jubilant Pharmova S&P BSE HEALTHCARE
1-Day -0.03% -0.68% 0.69%
1-Month 16.28% -0.34% -0.78%
1-Year 121.43% 166.97% 42.85%
3-Year CAGR 78.79% 23.34% 20.14%
5-Year CAGR 83.49% 16.79% 26.11%

* Compound Annual Growth Rate

Here are more details on the MARKSANS PHARMA. share price and the Jubilant Pharmova share price.

Moving on to shareholding structures...

The promoters of MARKSANS PHARMA. hold a 43.9% stake in the company. In case of Jubilant Pharmova the stake stands at 50.7%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of MARKSANS PHARMA. and the shareholding pattern of Jubilant Pharmova.

Finally, a word on dividends...

In the most recent financial year, MARKSANS PHARMA. paid a dividend of Rs 0.6 per share. This amounted to a Dividend Payout ratio of 8.6%.

Jubilant Pharmova paid Rs 5.0, and its dividend payout ratio stood at 109.5%.

You may visit here to review the dividend history of MARKSANS PHARMA., and the dividend history of Jubilant Pharmova.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Indian Rupee at Record Low | Belrise Industries IPO | Top Buzzing Stocks Today Indian Rupee at Record Low | Belrise Industries IPO | Top Buzzing Stocks Today(Pre-Open)

On Thursday, Indian share markets traded lower throughout the trading session and ended on a weak note.